olivlawolivlaw

olivLaw · European equity research

Hiscox Ltd HSX.L

United Kingdom · London Stock Exchange · Vertical: Listed companies from United Kingdom

19.80GBP−0.50% · 1 dayClose 05 Nov 2026

Hiscox is a specialty insurance group active in retail insurance, the London insurance market and reinsurance. In 2025 management launched an accelerated transformation programme meant to deliver annual benefits of 200 million USD from 2028, in a hard reinsurance market and under cost pressures.

At the close of 05 Nov 2026, Hiscox Ltd (HSX.L) stock was 19.80 GBP (−0.50% on the day), with beta 0.49, 52-week range 13.08–19.90 GBP.

Data as of · AI analysis dated · Source: ESEF annual reports and closing prices, computed by olivLaw.

Market cap
unavailable
shares as of 31 Dec 2025
P/E (TTM)
unavailable
Diluted EPS TTM 1.75 · TTM to 31 Dec 2025
E/P (TTM)
unavailable
TTM to 31 Dec 2025
Dividend yield
unavailable
Beta (2y)
0.49
Volatility (1y) 24%
52-week range
13.0819.90

Price history

Loading chart…

Technical reading

RSI (14)
70.0
strong (55–70)
Bollinger (20, 2)
17.77 – 19.62
above the upper band · %B 1.10 · band width 9.9%
SMA 50 / 200
18.69 / 17.13
uptrend (price > SMA50 > SMA200)
MACD (12, 26, 9)
0.23 / 0.06
MACD above signal

Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).

Performance

CompanyEURO STOXX 50vs EURO STOXX 50Vertical median
1 month+7.0%−0.6%+7.7 pp—
3 months+9.3%−4.2%+13.5 pp—
6 months+21.2%+4.3%+16.8 pp—
Year to date+39.1%+7.5%+31.6 pp—
1 year+44.1%+9.9%+34.2 pp+6.7%
3 years+104.9%+49.8%+55.0 pp+24.8%
5 years+140.2%+42.8%+97.4 pp—
Max drawdown (1y)
−7.6%
19 May 2026 → 05 Jun 2026
Max drawdown (5y)
−21.4%
03 May 2023 → 31 Oct 2023
Compound annual growth (5y)
+19.2%
EURO STOXX 50 +7.4%

Price returns, dividends excluded.

Quarterly results

ESEF annual reports carry no quarters: the results are annual (below).

E/P over time

the price (USD) and the reports are in different currencies

E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.

Fiscal years

Fiscal year202320242025
Revenueunavailableunavailableunavailable
Revenue YoYunavailableunavailableunavailable
Net income712.0 m627.2 m604.1 m
Net income YoYunavailable−11.9%−3.7%
Diluted EPS2.021.781.75
Diluted EPS YoYunavailable−11.6%−1.7%
net %unavailableunavailableunavailable
Free cash flow231.0 m109.3 m71.5 m

Balance sheet & financial health

Fiscal year 2025 · 31 Dec 2025

Cash
878.0 m USD
Financial debt
unavailable USD
Net debt
unavailable USD
Equity
3.9 bn USD
Total assets
12.2 bn USD
Debt / equity
unavailable
Current ratio
unavailable
ROE
15.8%
ROA
5.2%
FCF margin
unavailable

Financial statements (source on every figure)

Revenue and net income (USD)

Income statement · USD

Interest expense
2023
50.0 m
2024
53.1 m
2025
66.8 m

esef· 18 Mar 2026verified

Pre-tax income
2023
625.9 m
2024
685.4 m
2025
732.7 m

esef· 18 Mar 2026verified

Income tax
2023
-86.1 m
2024
58.2 m
2025
128.6 m

esef· 18 Mar 2026verified

Net income
2023
712.0 m
2024
627.2 m
2025
604.1 m

esef· 18 Mar 2026verified

Diluted EPS
2023
2.02
2024
1.78
2025
1.75

esef· 18 Mar 2026verified

Dividend per share
2023
—
2024
0.30
2025
—

esef· 18 Mar 2026verified

Balance sheet · USD

Cash
2023
1.4 bn
2024
1.2 bn
2025
878.0 m

esef· 18 Mar 2026verified

Property, plant & equipment, net
2023
130.3 m
2024
125.6 m
2025
108.6 m

esef· 18 Mar 2026verified

Total assets
2023
11.1 bn
2024
11.2 bn
2025
12.2 bn

esef· 18 Mar 2026verified

Total liabilities
2023
7.8 bn
2024
7.6 bn
2025
8.2 bn

esef· 18 Mar 2026verified

Equity
2023
3.3 bn
2024
3.7 bn
2025
3.9 bn

esef· 18 Mar 2026verified

Shares outstanding at year end
2023
345.5 m
2024
342.4 m
2025
334.3 m

esef· 18 Mar 2026derived

Cash flow · USD

Operating cash flow
2023
232.1 m
2024
114.4 m
2025
72.8 m

esef· 18 Mar 2026verified

Capex
2023
1.1 m
2024
5.1 m
2025
1.3 m

esef· 18 Mar 2026verified

Free cash flow
2023
231.0 m ≈
2024
109.3 m ≈
2025
71.5 m ≈

esef· 18 Mar 2026derived

Investing cash flow
2023
-34.2 m
2024
-38.5 m
2025
-113.4 m

esef· 18 Mar 2026verified

Financing cash flow
2023
-128.9 m
2024
-282.6 m
2025
-357.2 m

esef· 18 Mar 2026verified

Share repurchases
2023
0
2024
149.1 m
2025
275.7 m

esef· 18 Mar 2026verified

Computed indicators

Growth

Revenue growth (YoY)
unavailable
input data missing
Revenue CAGR 3Y
unavailable
input data missing
Revenue CAGR 5Y
unavailable
input data missing
EBIT growth (YoY)
unavailable
input data missing
Net income growth (YoY)
-3.7%
computed by olivLawFY 2025
Net income CAGR 3Y
unavailable
input data missing
Net income CAGR 5Y
unavailable
input data missing
EPS growth (YoY)
-1.7%
computed by olivLawFY 2025
EPS CAGR 3Y
unavailable
input data missing
EPS CAGR 5Y
unavailable
input data missing
FCF growth (YoY)
-34.6%
computed by olivLawFY 2025

Profitability

Gross margin
unavailable
input data missing
EBITDA margin
unavailable
input data missing
EBIT margin
unavailable
input data missing
Net margin
unavailable
input data missing
FCF margin
unavailable
input data missing

Returns

ROE
15.8%
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025
ROA
5.2%
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025
ROIC
unavailable
input data missing
ROCE
unavailable
input data missing
Payout ratio (EPS)
17.1%
computed by olivLawFY 2025
Payout ratio (FCF)
unavailable
input data missing

Balance sheet

Net debt
unavailable
input data missing
Net debt / EBITDA
unavailable
input data missing
Debt / equity
unavailable
input data missing
Interest coverage
unavailable
input data missing

Liquidity

Current ratio
unavailable
input data missing
Quick ratio
unavailable
input data missing
Cash ratio
unavailable
input data missing

Cash

Operating cash flow
72.8 m USD
computed by olivLawFY 2025
Capital expenditure
1.3 m USD
computed by olivLawFY 2025
Free cash flow
71.5 m USD
computed by olivLawFY 2025
FCF conversion
11.8%
computed by olivLawFY 2025
Cash conversion
unavailable
input data missing

Efficiency

Days sales outstanding
unavailable
input data missing
Days inventory outstanding
unavailable
input data missing
Days payables outstanding
unavailable
input data missing
Cash conversion cycle
unavailable
input data missing

Market and valuation

Market capitalisation
unavailable
input data missing
Enterprise value
unavailable
input data missing
Market cap / net income TTM
unavailable
input data missing
P/E (TTM)
unavailable
input data missing
Earnings yield
unavailable
input data missing
P/B
unavailable
input data missing
P/S
unavailable
input data missing
EV/EBITDA
unavailable
input data missing
EV/EBIT
unavailable
input data missing
EV/Sales
unavailable
input data missing
P/FCF
unavailable
input data missing
FCF yield
unavailable
input data missing
Dividend yield
unavailable
input data missing
Shareholder yield (distributions)
unavailable
input data missing

1 indicators that do not apply to the sector.

Valuation

olivLaw classification

Insufficient data
What is missing
  • indicators available: 1 of at least 6
  • score weight coverage: 6.2% of at least 60%

A scoring methodology on indicators and valuation, not investment advice.

Closing price

19.80 GBP

05 Nov 2026Source: olivLaw, closing series

Market cap: unavailable

Price and reporting are in different currencies; market indicators are unavailable.

Key indicators

Market capitalisation
unavailable
input data missing
P/E (TTM)
unavailable
input data missing
P/B
unavailable
input data missing
EV/EBITDA
unavailable
input data missing
ROE
15.8%
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025
Net margin
unavailable
input data missing
Revenue growth (YoY)
unavailable
input data missing
Dividend yield
unavailable
input data missing

Coverage and freshness

18/37 reporting lines present
Latest full fiscal year: 2025
Latest reported period: 31 Dec 2025
Latest balance sheet date: 31 Dec 2025
Share count (cover of the latest filing), as of: 31 Dec 2025
Source: esefpublished 18 Mar 2026
verified 57derived 3

Score by group

6% · Insufficient data

Estimated value range

Low
20.73
USD per share
Mid
26.84
USD per share
High
37.53
USD per share
Price: unavailable
Potential to the central value: unavailable (value / price − 1)
Margin of safety: unavailable (1 − price / value)
Agreement between methods: single method · 1 methods used · 1 independent bases

The combined range = the median of the valid methods' low, central and high values; it is not a probability interval and does not cover every result. Envelope of all methods: 20.73 – 37.53 USD.

Methods computed but outside the aggregate range: Dividend discount (DDM) (a small share of earnings is paid as dividends (capital returns through buybacks): the dividend model does not describe the value and stays outside the aggregate).

Valuation assumptions are editorial choices, not measured; beta is not measured.

Method ranges (USD per share)

— — Mid · ▏ Price

Valuation methods

  • DCF (discounted cash flow)unavailable · input data missing
  • Peers: EV/EBITDAunavailable · net debt missing: EV cannot be bridged to equity (missing debt is not zero)
  • Peers: P/E20.73 – 37.53 (Mid 26.84)
    18 companies used · median multiple 15.3x · quartiles 11.8x – 21.4x
    0EV1.L, ABDN.L, ABF.L, AIRE.L, AJB.L, ALFA.L, AMIF.L, APN.L, APTD.L, ASHM.L, AUTO.L, BAB.L, BAG.L, BATS.L, BBY.L, BCG.L, BKG.L, BME.L
  • Dividend discount (DDM)outside the aggregate3.93 – 5.28 (Mid 4.51)
    a small share of earnings is paid as dividends (capital returns through buybacks): the dividend model does not describe the value and stays outside the aggregate

Assumptions (illustrative, editorial)

Risk-free rate
4.3%
Equity risk premium
5.0%
Beta (default)
1.00
Cost of equity
9.3%
Terminal growth
2.5%

Factor scorecard

Insufficient data

Minimum-evidence gate: indicators available: 1 of at least 6; score weight coverage: 6.2% of at least 60%

FactorValueScoreWeight used
ROIC · Qualityunavailableunavailable—
Net margin · Qualityunavailableunavailable—
FCF conversion · Quality11.8%0 (on a fixed band)100%
Revenue CAGR 3Y · Growthunavailableunavailable—
EPS CAGR 3Y · Growthunavailableunavailable—
Net debt / EBITDA · Balance sheetunavailableunavailable—
Interest coverage · Balance sheetunavailableunavailable—
Current ratio · Balance sheetunavailableunavailable—
P/E (TTM) · Valuationunavailableunavailable—
EV/EBITDA · Valuationunavailableunavailable—
FCF yield · Valuationunavailableunavailable—
Shareholder yield (distributions) · Returnsunavailableunavailable—
Payout ratio (FCF) · Returnsunavailableunavailable—

Factors without a value were dropped; the remaining weights were renormalised.

Score groups

  • Balance sheet· partialunavailable · 0/3 factors with a value
  • Growth· partialunavailable · 0/2 factors with a value
  • Quality· partial0/100 · 1/3 factors with a value
  • Returns· partialunavailable · 0/2 factors with a value
  • Valuation· partialunavailable · 0/3 factors with a value

A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.

Memo

HISCOX LTD (HSX.L). Latest full fiscal year: 2025; data up to 2025-12-31.

Figures computed from the financial statements: ROE 15.8%.

The estimated value range is 20.73–37.53 USD per share (median of 1 methods, agreement: single method); assumptions are illustrative. The range is the median of the methods' low, central and high values, not a probability interval.

Insufficient data for a verdict (indicators available: 1 of at least 6; score weight coverage: 6.2% of at least 60%).

Text generated deterministically from the figures shown; no language model. Not investment advice.

What supports the thesis

No signal among the computed factors. That is not an absence of risk: factors without data were not assessed, and business risks (margins, inventory, demand) are in the source-based analysis.

What contradicts it

  • FCF conversion: 11.8%

Not assessed (insufficient data or a ratio without meaning): ROIC, Net margin, Revenue CAGR 3Y, EPS CAGR 3Y, Net debt / EBITDA, Interest coverage, Current ratio, P/E (TTM), EV/EBITDA, FCF yield, Shareholder yield (distributions), Payout ratio (FCF).

Versus the vertical median

Listed companies from United Kingdom · same country · compared with 40 companies

Multiples and returns vs the median

P/E
—
vertical median 16.3x
EV/EBITDA
—
vertical median —
P/S
—
vertical median 1.5x
P/B
—
vertical median 2.1x
ROE
15.8%
vertical median 13.9%
above median (+14.0%)
Net margin
—
vertical median 10.7%
EBIT margin
—
vertical median 21.1%
Revenue YoY
—
vertical median 7.5%
Net debt/EBITDA
—
vertical median —
Dividend yield
—
vertical median 2.8%

Companies in the vertical

Market capP/EROENet marginRevenue YoY1A / 3A
BATS.LBritish American Tobacco P.L.C.104.3 bn13.516.5%30.3%−1.0%+7% / +88%
ABF.LAssociated British Foods PLC14.7 bn14.39.2%5.3%−3.1%−5% / −15%
0EV1.LCarnival PLC5.5 bn4.146.7%13.4%+6.4%unavailable / unavailable
BAB.LBabcock International Group PLC5.1 bn24.734.7%4.1%+7.2%−10% / +158%
AUTO.LAutotrader Group PLC4.8 bn16.460.2%47.1%+3.9%−13% / −23%
BBY.LBalfour Beatty PLC4.2 bn16.323.2%2.8%+15.2%+20% / +160%
ABDN.LAberdeen Group PLC4.1 bn10.88.0%28.9%−2.1%+11% / +41%
BKG.LThe Berkeley Group Holdings PLC3.6 bn11.38.8%13.4%−4.2%−0% / −22%
BME.LB&M European Value Retail PLC2.9 bn17.421.2%2.8%+3.7%+68% / −51%
AJB.LAj Bell PLC2.4 bn22.849.9%33.1%+18.0%+8% / +128%
ASHM.LAshmore Group PLC1.4 bn13.913.1%71.6%−0.1%+28% / +18%
BCG.LBaltic Classifieds Group PLC1.2 bn23.215.8%57.6%+6.9%−99% / −99%
APN.LApplied Nutrition PLC763.6 m36.241.2%19.7%+24.2%+71% / unavailable
BAG.LA.G. Barr P.L.C.671.9 m14.414.4%10.8%+4.0%−7% / +26%
ASC.LAsos PLC494.5 m—-81.3%-12.0%−14.7%+71% / +8%
ALFA.LAlfa Financial Software Holdings PLC486.8 m16.361.5%23.8%+15.3%−28% / +10%
AML.LAston Martin Lagonda Global Holdings PLC344.3 m—-93.4%-39.2%−20.6%−45% / −85%
APTD.LAptitude Software Group PLC111.3 m28.57.2%6.2%−7.3%−30% / −23%
BMS.LBraemar PLC78.3 m39.22.7%1.7%−4.4%+13% / −11%
AMGO.LAmigo Holdings PLC9.9 m———−81.9%+325% / +844%
ASBE.LAssociated British Engineering PLC605.3 k—-19.1%—unavailableunavailable / unavailable
AMIF.LAmicorp Fs (uk) PLC221.6 k0.127.5%9.1%+8.1%unavailable / unavailable
AAF.LAirtel Africa PLC——24.1%10.6%+29.5%−7% / +164%
AAL.LAnglo American PLC——-19.3%-20.2%+4.5%+30% / +76%
ACG.LAcg Metals Limited——-80.3%-32.0%+134.8%+60% / +63%

1- and 3-year price returns: for HSX.L from daily closes (the same as the performance table), for the other companies from month-end closes.

olivLaw engine forecast

The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.

The engine has no published run for this company yet.

Valuation scenarios (editable assumptions)

Illustrative scenarios

Scenarios are not available. input data missing

AI analysis

AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

In brief

Hiscox is a specialty insurance group active in retail insurance, the London insurance market and reinsurance. In 2025 management launched an accelerated transformation programme meant to deliver annual benefits of 200 million USD from 2028, in a hard reinsurance market and under cost pressures.

SWOT

Strengths

  • Recognised underwriting expertise and an entrepreneurial culture that support relations with brokers and clients.
  • Investment portfolio dominated by high-quality instruments of relatively short duration.
  • Presence in three complementary segments: retail, the London market and reinsurance.

Weaknesses

  • Dependence on one major reinsurer, with a significant concentration of exposure.
  • Complexity of IT systems and a large number of applications and suppliers that raise costs.
  • Sensitivity of portfolio value to interest rate movements and asset valuations.

Opportunities

  • Growth in retail through new products, distribution partnerships and new geographic markets.
  • Automation and use of artificial intelligence to reduce costs and speed up services.
  • Expansion of specialty lines where the group has technological and expertise advantages.

Threats

  • Softening rates in some segments could reduce margins in the short term.
  • Rising litigation and social inflation could increase claim costs.
  • Catastrophic events and cyber attacks could generate major losses.

Risks

  • Underwriting riskhigh

    Premiums collected could prove insufficient to cover future claims if pricing or risk selection proves wrong.

  • Reserving riskhigh

    Reserve estimates for liability claims could be exceeded if litigation grows faster than anticipated.

  • Market and interest rate riskmedium

    A fall in the value of fixed income instruments and private credit funds could reduce available capital.

  • Reinsurance credit riskmedium

    Failure of a major reinsurer to pay could generate losses, given the concentration of exposure.

  • Operational and cyber risklow

    Supplier disruption or cyber attacks could disrupt operations during the transformation.

Investment thesis

What would need to be true (bull case)

  • If the transformation programme delivers the promised benefits, operating margins could rise significantly after 2026.
  • Retail growth, supported by new products and partnerships, could accelerate revenue across several markets.
  • Underwriting discipline in reinsurance could sustain very good combined ratios while rates remain adequate.

What would break the thesis

  • If rates soften quickly in the London market, premium growth could slow without margin improvement.
  • Rising litigation could raise reserves and erode results in the following years.
  • Transformation costs could exceed the expected benefits if execution is delayed.

What to watch

  • Progress of the transformation programme and benefits realised against the annual target2026
  • Evolution of ICWP in Hiscox Retail, especially the announced acceleration of growthQ1 2027
  • Evolution of underwriting rates in the London market and in reinsurancenext 10-K
  • Exposure to the major reinsurer and development of casualty reserves2027

Products, market & competition

AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

The business

Hiscox Ltd runs three main segments: Hiscox Retail, which sells insurance directly and through partners to individuals and small businesses, Hiscox London Market, specialised in commercial and complex risk insurance through the London market, and Hiscox Re, the reinsurance arm. The group invests its own funds and its insurance obligations in debt instruments, equities and private credit funds, and the board monitors the portfolio's sensitivity to rates and prices. Current strategy aims at profitable growth by extending the specialty model into new markets, transforming operations and diversifying distribution channels.

The investment portfolio is dominated by fixed income instruments, with a substantial weight in high-quality corporate and government bonds of relatively short duration. Equity exposure is limited and diversified, and part of the assets sits in absolute return strategies to support underwriting capacity in financial market downturns. Risk management works through a framework built on three lines of defence, with dedicated committees for catastrophe, cyber, casualty and reserving.

The group is trying to reduce operational complexity by rationalising IT applications and its supplier base, while automating processes and using artificial intelligence in underwriting and broker relations. A multi-year collaboration with Google Cloud signed at the end of 2025 supports this direction. Management states that the business model remains based on underwriting expertise, an entrepreneurial culture and sector specialism.

Segments

Hiscox Retail

The retail segment, which serves individuals and small businesses through digital distribution and partnerships, was expected to accelerate ICWP growth in 2026, supported by new products, new distribution deals and new markets. Management targets an undiscounted combined ratio within the 89%-94% operating range, with gradual improvement.

Hiscox London Market

The London market for commercial and complex risk insurance manages pricing cycles at a micro-segment level, as rates soften in some areas. The division relies on its diverse portfolio and its ability to innovate to find attractive business where it has complementary expertise and technological advantages.

Hiscox Re

The reinsurance division has captured the hard reinsurance market, with significant net growth over the last five years and undiscounted combined ratios in the 60s in recent years. Gross premium depends on the availability of third-party capital and growth in specialty lines.

Market context

The specialty insurance market in the UK and Europe was shaped in 2025 by geopolitical tensions, US tariffs, slow economic growth in Britain and Europe and a rising propensity to litigation. Economic and social inflation, supply chain disruption and the threat of cyber attacks required continuous price reviews.

Reinsurance has been in a hard cycle, with good rates for property risks exposed to natural catastrophes, while the London market shows signs of softening in some lines. Climate change and the frequency of extreme events remain central factors for pricing and capital.

Trends

  • Hard reinsurance cyclemixed

    Higher reinsurance rates supported the growth of Hiscox Re and very good combined ratios. If the market softens, margins could decline.

  • Social inflation and litigationheadwind

    A rising tendency to litigate and higher liability claim costs could increase the reserves needed and require price reviews.

  • Artificial intelligence and digitalisationtailwind

    Using AI in underwriting and broker relations could reduce costs and improve client experience, provided governance is strong.

  • Geopolitical and financial market volatilityheadwind

    Regional conflicts and market shocks can affect the value of the investment portfolio and underwriting capacity, especially if interest rates move sharply.

Competitive position

Hiscox competes with specialty insurers and international insurance and reinsurance groups, both in retail and in the London commercial market. Its advantage lies in sector expertise, global presence and the ability to adapt quickly to market cycles.

In reinsurance, competition depends on available capacity and financial ratings, and the group depends on a limited number of reinsurers with acceptable credit. The concentration of exposure to one major reinsurer is a point of attention.

  • Lloyd's of London syndicates

    Lloyd's syndicates compete with Hiscox London Market in commercial and complex risk insurance.

  • Munich Reinsurance Company

    A major reinsurer for the group and, at the same time, a direct competitor in reinsurance.

  • Specialty insurance groups

    Commercial specialty insurance groups compete for the same clients and brokers.

  • Global reinsurance groups

    Global reinsurers compete for capacity and for specialised reinsurance transactions.

News & filings

In the press

Annual reports (ESEF)

Sources

  1. [1] Annual report, fiscal year ended 2025-12-31 (ESEF) · SEC / Hiscox Ltd · 31 Dec 2025

Figures computed by olivLaw from ESEF annual reports and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.